摘要
Abstract
Objective To evaluate the clinical efficacy and explore the clinical applicability of minimally invasive hematoma drainage for treatment of hypertensive cerebral hemorrhage. Methods 78 patients with hypertensive cerebral hemorrhage treated in our hospital from May 2011 to May 2014 were selected and randomly divided into experimental group and control group.The control group was given with conventional craniotomy for hematoma clearance while the experimental group was given with minimally invasive hematoma drainage.The operation duration,intraoperative blood loss,hematoma clearance rate,postoperative neural function deficit score,therapeutic effect and life quality were ob-served. Results Both groups had successful surgery and no craniotomy was adopted in the experimental group.The ex-perimental group had better results in operation duration,intraoperative blood loss and hematoma clearance rate than those of the control group,the difference was significant (P<0.05).The two groups had no significant difference in neural function deficit score before treatment (P>0.05);both groups had decreased neural function deficit score after treatment, with statistical significance (P<0.05);the experimental group had better improvement than that of the control group,with statistical significance (P<0.05).The experimental group had better therapeutic effect than that of the control group,with statistical significance (χ²=4.4928,P=0.0340).The total effective rate of life quality improvement was 97.5% in the ex-perimental group and 84.2%in the control group,with statistical significance (字2=4.2131,P=0.0401). Conclusion In line with the concept of minimal invasiveness,minimally invasive hematoma drainage can promote fast remission of neural function deficit symptoms and improve postoperative life quality.关键词
微侵袭血肿引流术/高血压脑出血/临床疗效Key words
Minimally invasive hematoma drainage/Hypertensive cerebral hemorrhage/Clinical efficacy分类
医药卫生
